These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 30006541)
41. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029 [TBL] [Abstract][Full Text] [Related]
42. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling. Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
45. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. Xiang J; Bian C; Wang H; Huang S; Wu D J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908 [TBL] [Abstract][Full Text] [Related]
46. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767 [TBL] [Abstract][Full Text] [Related]
50. A microRNA code for prostate cancer metastasis. Bonci D; Coppola V; Patrizii M; Addario A; Cannistraci A; Francescangeli F; Pecci R; Muto G; Collura D; Bedini R; Zeuner A; Valtieri M; Sentinelli S; Benassi MS; Gallucci M; Carlini P; Piccolo S; De Maria R Oncogene; 2016 Mar; 35(9):1180-92. PubMed ID: 26073083 [TBL] [Abstract][Full Text] [Related]
51. miR-539 inhibits prostate cancer progression by directly targeting SPAG5. Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000 [TBL] [Abstract][Full Text] [Related]
52. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer. Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862 [TBL] [Abstract][Full Text] [Related]
53. Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K Oncotarget; 2014 Jun; 5(11):3770-84. PubMed ID: 25004126 [TBL] [Abstract][Full Text] [Related]
54. MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. Wang QY; Zhou CX; Zhan MN; Tang J; Wang CL; Ma CN; He M; Chen GQ; He JR; Zhao Q Cell Death Dis; 2018 Jul; 9(7):752. PubMed ID: 29970901 [TBL] [Abstract][Full Text] [Related]
55. miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Wa Q; Huang S; Pan J; Tang Y; He S; Fu X; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou C Mol Ther Nucleic Acids; 2019 Dec; 18():567-579. PubMed ID: 31678733 [TBL] [Abstract][Full Text] [Related]
56. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668 [TBL] [Abstract][Full Text] [Related]
58. EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1. Chang YS; Chen WY; Yin JJ; Sheppard-Tillman H; Huang J; Liu YN Cancer Res; 2015 Aug; 75(15):3077-86. PubMed ID: 26071255 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma. Guo J; Wang M; Liu X J Exp Clin Cancer Res; 2015 Sep; 34(1):91. PubMed ID: 26338045 [TBL] [Abstract][Full Text] [Related]
60. Facilitating colorectal cancer cell metastasis by targeted binding of long non-coding RNA ENSG00000231881 with miR-133b via VEGFC signaling pathway. Zhou J; Zou Y; Hu G; Lin C; Guo Y; Gao K; Wu M Biochem Biophys Res Commun; 2019 Jan; 509(1):1-7. PubMed ID: 30581003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]